• 1. Department of Cardiology, Affiliated Hospital of Binzhou Medical College, Binzhou, Shandong 256603, P. R. China;
  • 2. Department of Cardiology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P. R. China;
Export PDF Favorites Scan Get Citation

Objective To investigate the association between CYP11B2 gene polymorphism and left ventricular hypertrophy in Chinese hypertensive patients by the means of meta-analysis. Methods Literatures about case control study on the association of CYP11B2 gene polymorphism and left ventricular hypertrophy were searched from January 1980 to December 2012.The electronic databases searched included China national knowledge internet,Chinese biological medicine disk,Vip fulltext database,Wanfang fulltext database and Pubmed.Odds ratio (OR) of CYP11B2 genotype distributions in left ventricular hypertrophy (LVH) patients against NLVH patients were analyzed.RevMan 5.1 software was applied for investigating heterogeneity among individual studies and summarizing effects across studies by proper statistical methods. Results Six case-control studies were selected finally.A total of 1 791 hypertensive patients were included.The pooled OR (95% CI) of CC vs.TT+TC genotype was 1.21(0.80,1.81)(Z=0.91,P=0.36),the pooled OR (95% CI) of (TC+CC) vs.TT genotype was 1.16(0.68,1.98)(Z=0.54,P=0.59),and the pooled OR (95% CI) of C vs.T allele was 1.09(0.78,1.54)(Z=0.51,P=0.61). Conclusion The genotype of CYP11B2 polymorphism is not associated with an increase risk of left ventricular hypertrophy in Chinese hypertensive patients.

Citation: MABao-xin, LIUXian-liang, LIHua, LIZong-qing. Meta-analysis on the Association of CYP11B2 Gene Polymorphism and Left Ventricular Hypertrophy in Chinese Hypertensive Patients. West China Medical Journal, 2014, 29(2): 239-242. doi: 10.7507/1002-0179.20140074 Copy

  • Previous Article

    Clinical Characteristics of Acute Kidney Injury in Hospitalized Patients with Chronic Obstructive Pulmonary Disease
  • Next Article

    Observation of the Clinical Efficacy and Safety of Reteplase in Prehospital Thrombolysis for ST-segment Elevation Acute Myocardial Infarction